White label ELPA - ClinicalTrials.eu

Study of Opevesostat, Olaparib, and Cabazitaxel in Patients with Advanced Prostate Cancer

Recruiting

1 1 1 1
Investigated diseases:
- Prostate cancer
- Hormone-refractory prostate cancer
Investigated drugs:
+2
Study on the Effectiveness of Oral Antibiotics Gentamicin and Metronidazole in Patients with Acute Mesenteric Ischemia

Recruiting

3 1 1
Investigated diseases:
- Intestinal ischaemia
Investigated drugs:
Study of Posaconazole for Preventing Fungal Infections in Patients Receiving Stem Cell Transplants for Blood Cancer

Recruiting

2 1 1 1
Investigated diseases:
- Allogenic stem cell transplantation
Investigated drugs:
- Posaconazole
Study on Dexamethasone for Patients with Advanced Relapsed or Refractory Multiple Myeloma

Recruiting

3 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
- Dexamethasone
Study on the Safety and Effects of ION440 for Patients with MECP2 Duplication Syndrome

Recruiting

2 1 1
Investigated diseases:
- Myelodysplastic syndrome
Investigated drugs:
- Ion440
Comparing Lidocaine-Prilocaine Cream and Lidocaine Injection for First-Degree Perineal Tear Repair in Women

Recruiting

3 1 1 1
Investigated diseases:
- Perineal injury
Investigated drugs:
Study on the Safety and Tolerability of SNDX-5613 for Patients with Relapsed or Refractory Acute Leukemias

Recruiting

2 1 1
Investigated diseases:
- Acute leukaemia
Investigated drugs:
- N-Ethyl-2-[4-[7-[[4-(Ethylsulfonylamino)Cyclohexyl]Methyl]-2,7-Diazaspiro[3.5]Nonan-2-Yl]Pyrimidin-5-Yl]Oxy-5-Fluoro-N-Propan-2-Ylbenzamide
- Revumenib
Study on Long-Term Safety of AAVAnc80-hOTOF Gene Therapy for Patients with Sensorineural Hearing Loss Due to Otoferlin Gene Mutations

Recruiting

4 1 1
Investigated diseases:
- Deafness
Investigated drugs:
- Aavanc80-3’Hotof
- Aavanc80-5’Hotof
Study of IMP1734, Paclitaxel, and Abiraterone for Patients with Advanced Solid Tumors

Recruiting

2 1 1 1
Investigated diseases:
- Neoplasm
Investigated drugs:
Study on Oxytocin and Self-Compassion Training for Patients with Borderline Personality Disorder

Recruiting

3 1 1
Investigated diseases:
- Borderline personality disorder
Investigated drugs:
- Oxytocin

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies